Fingerprint Dive into the research topics of 'Initial testing (stage 1) of the PARP inhibitor BMN 673 by the pediatric preclinical testing program: PALB2 mutation predicts exceptional in vivo response to BMN 673'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically